Venlafaxine versus Citalopram in treatment of depressio

Not Applicable

• Conditions: F32.0 ,F32; Major depressive disorder.; Mild depressive episode , Moderate depressive episode

• Registration Number: IRCT201203048513N1
• Lead Sponsor: Shahid Sadughi University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 53

Inclusion Criteria

inclusion criteria :mild to moderate major depressive disorder ; patients with primary depression or with any symptom in a month ago

exclusion criteria : severe depression ;bipolarity ; anxiety disorder ; alcoholic or drug abuse ; patients with other significant medical diseases ; psychotic disorder ; pregnant women and breast feeding mothers

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evel of recovery of depression. Timepoint: before of study & follow up visits every a 2-weeksfor 8 weeks. Method of measurement: cheking of hamilton score.

Secondary Outcome Measures

Name	Time	Method
Side effect of drugs. Timepoint: every 2 weeks for 8 weeks. Method of measurement: with history taking & blood pressure cheking.